Major depressive disorder (MDD)
Conditions
Interventions
None listed
Sponsors
Takeda Pharmaceutical Company Limited.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Experience with at least one of the cognitive function scales targeted in this study. Psychiatrists.
Exclusion criteria
Exclusion criteria: None
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Identify the characteristics of each targeted cognitive function scale. Participant will rate the following perspectives on a scale of 1-5. (difficulty of introducing a new routine clinical practice / knowledge and experience required for accurate evaluation / time required from explanation to completion / difficulty of result calculation / knowledge and experience required for effective utilization of results) | — |
Secondary
| Measure | Time frame |
|---|---|
| Estimate the usage rate of each cognitive function scale. Participants will answer whether they had experience using each rating scale. | — |
Countries
Japan
Contacts
Public ContactFumie Tokuda
Takeda Pharmaceutical Company Limited. Japan Medical Office
Outcome results
None listed